Leith Wheeler Investment Counsel Ltd. reduced its stake in shares of Globe Life Inc. (NYSE:GL - Free Report) by 3.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 114,709 shares of the company's stock after selling 4,087 shares during the period. Globe Life makes up approximately 0.9% of Leith Wheeler Investment Counsel Ltd.'s investment portfolio, making the stock its 24th biggest holding. Leith Wheeler Investment Counsel Ltd. owned 0.14% of Globe Life worth $12,792,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. World Investment Advisors LLC boosted its stake in shares of Globe Life by 34.7% in the third quarter. World Investment Advisors LLC now owns 5,704 shares of the company's stock worth $604,000 after buying an additional 1,469 shares during the last quarter. Retirement Systems of Alabama boosted its stake in shares of Globe Life by 6.4% in the third quarter. Retirement Systems of Alabama now owns 19,702 shares of the company's stock worth $2,087,000 after buying an additional 1,179 shares during the last quarter. DGS Capital Management LLC purchased a new position in Globe Life during the third quarter worth approximately $212,000. Principal Financial Group Inc. boosted its position in Globe Life by 9.0% during the third quarter. Principal Financial Group Inc. now owns 105,315 shares of the company's stock worth $11,154,000 after purchasing an additional 8,663 shares in the last quarter. Finally, Versant Capital Management Inc boosted its position in Globe Life by 388.0% during the fourth quarter. Versant Capital Management Inc now owns 244 shares of the company's stock worth $27,000 after purchasing an additional 194 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on GL shares. Keefe, Bruyette & Woods increased their price target on Globe Life from $137.00 to $145.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 12th. Wells Fargo & Company cut their price target on Globe Life from $141.00 to $140.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. Evercore ISI raised Globe Life from an "in-line" rating to an "outperform" rating and raised their target price for the stock from $132.00 to $143.00 in a research note on Wednesday, January 8th. JPMorgan Chase & Co. raised their price target on Globe Life from $136.00 to $145.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 2nd. Finally, Piper Sandler raised their price target on Globe Life from $140.00 to $152.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 2nd. Four research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $137.55.
Read Our Latest Analysis on GL
Insider Buying and Selling
In other Globe Life news, CEO Frank M. Svoboda sold 11,000 shares of the stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $122.31, for a total value of $1,345,410.00. Following the transaction, the chief executive officer now directly owns 18,948 shares in the company, valued at $2,317,529.88. This represents a 36.73 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO James Matthew Darden sold 24,890 shares of the stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $121.52, for a total transaction of $3,024,632.80. Following the completion of the transaction, the chief executive officer now owns 38,973 shares in the company, valued at $4,735,998.96. This represents a 38.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.51% of the company's stock.
Globe Life Stock Up 0.5 %
GL stock opened at $123.56 on Tuesday. The company's 50 day moving average price is $124.14 and its 200 day moving average price is $116.51. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.05 and a current ratio of 0.05. Globe Life Inc. has a fifty-two week low of $71.50 and a fifty-two week high of $133.76. The firm has a market capitalization of $10.29 billion, a price-to-earnings ratio of 10.34 and a beta of 0.60.
Globe Life (NYSE:GL - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, topping analysts' consensus estimates of $3.12 by $0.02. Globe Life had a net margin of 18.53% and a return on equity of 22.32%. On average, equities research analysts anticipate that Globe Life Inc. will post 13.87 EPS for the current fiscal year.
Globe Life Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Thursday, July 3rd will be paid a dividend of $0.27 per share. The ex-dividend date is Thursday, July 3rd. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.87%. Globe Life's payout ratio is 9.04%.
Globe Life Profile
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Featured Articles
Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.